Pfizer Just Locked Next Growth Path: What Investors Should Know
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Starting retirement planning can be daunting. Discover essential steps to guide you in creating a successful retirement plan.
15,801 articlesPfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
TriSalus investors are eyeing the Q1 2026 earnings update to gauge cash runway, pipeline progress, and milestone-driv...
Markets are pricing in a Warsh-influenced Fed shift that could widen bank margins. A trio of U.S. banks trading under...
A surprising uptick in the memory sector has traders asking, 'Why is SanDisk stock today?' While SanDisk isn’t traded...
Two under-the-radar oil stocks could become big movers. This guide shows how to spot overlooked stocks before they so...
Investors often wonder if the memory chip darling Micron is still worth buying after a big run. This guide breaks dow...
Nvidia and Micron are central to AI data centers, but one may be the better buy for your portfolio. This guide breaks...
Mind Robotics has rapidly transformed Rivian's focus, reaching a multi-billion dollar valuation. Learn the two key wa...
Viktor has raised $75 million in a Series A to deploy an AI coworker inside Slack and Teams, aiming to automate repet...
When great growth ideas stumble, the long-term case often remains intact. This piece examines two names that have fal...
Jim Cramer’s steadfast rule on debt service coverage guides stock picks as higher interest rates persist. Investors w...
Oracle rides a rebound in AI spending with a hefty backlog and cloud growth; a 12-month target suggests meaningful up...